Nicoline Videbaek

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Nicoline Videbaek and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Nicoline

Nicoline Videbaek

Principal Scientist

Novo Nordisk A/S

Nicoline Videbæk is a Principal Scientist in the Department of Clinical Immunogenicity Analysis at Novo Nordisk A/S. She received her PhD in immunology from the University of Cambridge in 1999, and has over 20 years of experience in immunogenicity assessment for non-clinical and clinical studies. Nicoline has developed and validated immunogenicity assays, including in vitro neutralizing antibody assays, for peptide-based, monoclonal antibody-based, and hormone-based drugs. She is a member of the EBF nAb workgroup and offers advice on immunogenicity risk assessments, in addition to teaching in an immunogenicity course.

Talks About
#scientist

Preferred Locations
#Euriope

Speaking Engagements

Immunology for Biotherapeutics

Paid

Many of the exciting advances in drug discovery and development today concern the immune response and its manipulation and control. Our understanding of immune involvement in therapeutic disorders and their treatment is developing rapidly. T and B lymphocyte subsets, innate lymphoid cells (ILCs), macrophages, dendritic cells, and cytokines are all

02-02 October 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Nicoline Videbaek

Principal Scientist

Speaking Engagements

Immunology for Biotherapeutics